ProPhase Labs to Present at Investor Summit Group's Q4 Conference

Author's Avatar
Nov 08, 2022

GARDEN CITY, NY, Nov. 07, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced it will be participating in the Q4 Investor Summit Conference, which will take place on November 14, 2022 in New York, New York. ProPhase Labs’ CEO and Chairman of the Board of Directors, Ted Karkus will be presenting at 3:00 PM ET on November 14, 2022.